TP53 and colorectal carcinoma: QUE synergistically enhanced the sensitivity of HT-29 CRC cells to 5-FU by up-regulating the expression of p38, PTEN, Bax, and p53, but down-regulating the expression of AKT, mTOR and bcl-2 (37).